lobbying_activities: 3010107

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3010107	8c138b03-ef60-43bf-98ce-96b3c5932b22	Q2	BURRELL INTERNATIONAL GROUP LLC	401103483	ACER THERAPEUTICS	2023	second_quarter	PHA	COVID-19 therapeutics and Medical Countermeasures, Rare Disease, and Re-purposed drugs; Defense Appropriations for MCM Development	HOUSE OF REPRESENTATIVES,SENATE	20000		0	0	2023-07-18T12:52:00-04:00